Why are employers rethinking benefits in the face of rising prescription costs?
As prescription drug prices continue to rise across the U.S., employers are finding themselves at a crossroads. According to a recent Reuters report, more than 50% of large employers are expected to reduce health benefits by 2026, driven primarily by surging costs of specialty medications—particularly GLP-1 drugs used for weight management and diabetes. But cutting […]